All Type of News
Scope of bio-equivalent test exemtpion more defined.
The KFDA has refined the standards for the bio-equivalent test in order to enhance its credibility and announced it for legislation in conformance to the newly revised pharmaceutical affairs law.
The Article 23 (su...
24 drug companies penalized due to KGMP non-compliance
24 pharmaceutical companies including Taeguk Pharm. Co. found noncompliance to the KGMP to get administrative penal measures including a licence cancellation and a manufacturing suspension.
To prepare forthcoming i...
Specialized administration system for bio-engineering products to build up.
The KFDA plans to establish the Bio-engineering Products Division, taking care of all bio-engineering products to meet the new knowledge industrial needs, and the Division will build up a special administrative system...
Drug industry induced 100 mil. dollar foreign capitals.
According to "the status of foreign capital inducement in 2000" reported by the ministry of Industry and Energy the drug industry achieved 33 cases of foreign capital inducement covering about 98 million dollar in 200...
Pharmacy franchise business on green light
Many franchise pharmacies experienced a bitter business and slow sales last year mainly due to the medical strikes in connection with the medical and pharmacy role separation program, but it is foreseen that their bu...
Medical community welcome for injectable drugs to exclude from medical reform programs.
The medical community did not make any official comments on the government's plan for injectable drugs to exclude from the reform programs but rather internally welcome its progress favorably for them in the National ...
One year probation given to retail pharmacies already in unfair business collusion.
The Pharmaceutical Affairs Law Revision Subcommittee affiliated to the Health and Welfare Committee of the National Assembly finally decided all issues raised by the 3 way talks of the government, the medical and the ...
Quasi-drug price labelling system to postpone 6 more months.
The price labelling system applicable to all quasi-drugs as originally planned to implement from Jan. 1 this year has put off until coming June, considering a full probation period for manufacturers to consume all sto...
Business collusion between medical institutes and pharmacies to be rooted out.
While the revised bill of pharmaceutical affairs law is kept in deadlock mainly due to the crippled operation of the National Assembly, the MOHW has shown a definite position against the business collusion between med...
Service for pharmacy turned unfavorable after new reform system launched.
According to a survey conducted by the KPA correspondence 78% respondents to the enquete titled "Pharmacist's perception over drug companies" said that the service level provided by drug companies for retail pharmacie...
